In her new capacity, Tapley will prioritize strengthening commercial ties with wound care clinicians, skilled nursing facilities, and durable medical equipment providers. Her mandate includes scaling physician-direct and retail channels while coordinating with international partners to drive market performance. CEO Gilad Savion highlighted the appointment as a reflection of Tapley's leadership and the company’s commitment to internal advancement, expressing confidence in her ability to scale the firm’s global footprint.

Tapley brings over a decade of experience in managed care, cardiology, and nephrology to the executive team. She aims to position Lavior as a leader in the wound care sector by focusing on high-performing team development and clinical partnerships. The company, based in Miami, specializes in proprietary botanical technology derived from Inula viscosa, primarily serving patients managing diabetes through its specialized hydrogel and barrier cream product lines.